These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
228 related items for PubMed ID: 10064593
1. Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells. Rosário M, Paterson HF, Marshall CJ. EMBO J; 1999 Mar 01; 18(5):1270-9. PubMed ID: 10064593 [Abstract] [Full Text] [Related]
2. TC21 and Ras share indistinguishable transforming and differentiating activities. Graham SM, Oldham SM, Martin CB, Drugan JK, Zohn IE, Campbell S, Der CJ. Oncogene; 1999 Mar 25; 18(12):2107-16. PubMed ID: 10321735 [Abstract] [Full Text] [Related]
3. Activation of the Ral and phosphatidylinositol 3' kinase signaling pathways by the ras-related protein TC21. Rosário M, Paterson HF, Marshall CJ. Mol Cell Biol; 2001 Jun 25; 21(11):3750-62. PubMed ID: 11340168 [Abstract] [Full Text] [Related]
4. TC21 causes transformation by Raf-independent signaling pathways. Graham SM, Vojtek AB, Huff SY, Cox AD, Clark GJ, Cooper JA, Der CJ. Mol Cell Biol; 1996 Nov 25; 16(11):6132-40. PubMed ID: 8887643 [Abstract] [Full Text] [Related]
5. Signal transduction elements of TC21, an oncogenic member of the R-Ras subfamily of GTP-binding proteins. Movilla N, Crespo P, Bustelo XR. Oncogene; 1999 Oct 21; 18(43):5860-9. PubMed ID: 10557073 [Abstract] [Full Text] [Related]
6. Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation. Graham SM, Cox AD, Drivas G, Rush MG, D'Eustachio P, Der CJ. Mol Cell Biol; 1994 Jun 21; 14(6):4108-15. PubMed ID: 8196649 [Abstract] [Full Text] [Related]
7. Involvement of phosphatidylinositol 3-kinase, but not RalGDS, in TC21/R-Ras2-mediated transformation. Murphy GA, Graham SM, Morita S, Reks SE, Rogers-Graham K, Vojtek A, Kelley GG, Der CJ. J Biol Chem; 2002 Mar 22; 277(12):9966-75. PubMed ID: 11788587 [Abstract] [Full Text] [Related]
8. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes. Saez R, Chan AM, Miki T, Aaronson SA. Oncogene; 1994 Oct 22; 9(10):2977-82. PubMed ID: 8084601 [Abstract] [Full Text] [Related]
9. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Oldham SM, Clark GJ, Gangarosa LM, Coffey RJ, Der CJ. Proc Natl Acad Sci U S A; 1996 Jul 09; 93(14):6924-8. PubMed ID: 8692920 [Abstract] [Full Text] [Related]
13. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways. Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD. Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018 [Abstract] [Full Text] [Related]
15. Ornithine decarboxylase induction in transformation by H-Ras and RhoA. Shantz LM, Pegg AE. Cancer Res; 1998 Jul 01; 58(13):2748-53. PubMed ID: 9661886 [Abstract] [Full Text] [Related]
16. The insulin/Ras pathway of adipocytic differentiation of 3T3 L1 cells: dissociation between Raf-1 kinase and the MAPK/RSK cascade. Porras A, Santos E. Int J Obes Relat Metab Disord; 1996 Mar 01; 20 Suppl 3():S43-51. PubMed ID: 8680477 [Abstract] [Full Text] [Related]
17. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2). Koong AC, Chen EY, Mivechi NF, Denko NC, Stambrook P, Giaccia AJ. Cancer Res; 1994 Oct 15; 54(20):5273-9. PubMed ID: 7923153 [Abstract] [Full Text] [Related]